EFFECTIVENESS OF AGNIKARMA (THERAPEUTIC CAUTERIZATION) PROCEDURE WITH PANCHLOHASHALAKA IN MANAGEMENT OF VATAKANTAKA (CALCANEAL SPUR) : A CASE STUDY
DOI:
https://doi.org/10.70057/ijaar.2025.70304Keywords:
Agnikarma, calcaneal spur, vatakantaka, bindu agnikarma, panchloha shalaka, gulpha sandhiAbstract
Background: Pain in the heel due to prolonged walking, standing, or physical activity is a common modern complaint, with calcaneal spur being one of the leading causes. A calcaneal spur is a pointed bony outgrowth on the calcaneus, typically associated with pain and difficulty in routine activities. In Ayurveda, this condition is correlated with Vatakantaka, a type of Vatavyadhi, characterized by sharp, thorn-like pain in the heel. Acharya Sushruta has advocated Agnikarma (therapeutic cauterization) as an effective treatment for such conditions. Aim: To evaluate the efficacy of Agnikarma therapy in the management of calcaneal spur. Case Description: A 46-year-old female presented with heel pain and tenderness diagnosed as calcaneal spur. The condition was managed with three sittings of Agnikarma without any oral medication. After the second sitting, symptoms were partially relieved, and after the third sitting, pain and discomfort completely subsided. No adverse effects were observed during the procedure. Conclusion: The case demonstrated significant improvement in heel pain and overall mobility following Agnikarma therapy, highlighting its potential as a safe and effective treatment modality for calcaneal spur. Clinical Significance: Conventional management of calcaneal spur often provides only temporary relief and may involve prolonged use of analgesics or invasive procedures. Agnikarma offers a simple, minimally invasive, and cost-effective alternative with promising results in symptom alleviation and improved quality of life.
Downloads
Published
How to Cite
Issue
Section
Copyright (c) 2025 Sonali Malviya, Ram Sinha, Hari Prakash Sharma

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.